A complete response letter (CRL) from the FDA delays a product's entry to the market by an average of 14 months. Companies that receive the letters take an average of seven months just to respond to them. Imagine how much you could save if you could anticipate the FDA's concerns and address them before the agency issues the complete response letter? Now you can.
SciClone Pharmaceuticals has announced that Mark Lotter will resign from the position of CEO of the company’s China operations at the end of 2012. Lotter will also resign his position as a director of the company. Equities